NIH-funded research R01 grant

Improving consent processes for prenatal genetic screening in diverse populations

Official title: Supporting Just-in-Time Consent for Prenatal Screening in Diverse Populations

Funded at Mayo Clinic Jacksonville · NIH-10941749 · Data updated 2026-11-12

This study is looking to improve how we explain prenatal genetic screening to expectant parents, especially in places where support might be limited, so they can make informed choices that feel right for them without added stress.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionMayo Clinic Jacksonville
NIH-funded
Lab location1 site (Jacksonville, United States)
Project startSeptember 18, 2024
Project endJune 30, 2028
Funding year2024
Award (this year)$812,285
NIH project number1R01HG013718-01
Project IDNIH-10941749 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include pregnant individuals considering prenatal genetic screening, particularly those from diverse and low-resource backgrounds.

Less likely to help

Patients who are not pregnant or those who are not considering prenatal genetic screening may not benefit from this research.

What this research studies

This research focuses on enhancing the informed consent process for prenatal genetic screening, which provides noninvasive insights into potential fetal genetic conditions. It aims to address the ethical concerns surrounding the current practices of prenatal screening, particularly in low-resource settings, where adequate counseling and support may be lacking. By exploring the experiences and needs of pregnant individuals, the study seeks to develop better strategies for obtaining consent that align with patients' values and reduce unnecessary psychological stress. The research will involve diverse populations to ensure that the findings are applicable across different communities.

Why it matters

Potential benefit: If successful, this research could lead to improved informed consent practices that better support pregnant individuals and their families during prenatal screening.

How similar studies have gone: Previous research has highlighted the need for improved consent processes in prenatal screening, indicating that this approach is both relevant and necessary.

Where this research is happening

  • Mayo Clinic Jacksonville
    Jacksonville, United States
    Active

Researchers

  • Principal investigator: Allyse, Megan a. — Mayo Clinic Jacksonville
  • Study coordinator: Allyse, Megan a.

Related research

Other NIH-funded projects on the same topics.

  • Carotid artery treatment for people with artery narrowing who don’t have symptoms

    A large, international study is testing whether intensive medical care plus either carotid surgery or carotid stenting improves outcomes for people with high-grade carotid artery narrowing who have not yet had symptoms.

    NIH research Mayo Clinic Jacksonville · Jacksonville, United States · NIH-11595509

  • Antibiotic Allergy: Types, Triggers, and How they Work

    This grant aims to better understand why certain antibiotics trigger immediate allergic reactions and how to improve testing and diagnosis for patients with suspected antibiotic allergies.

    NIH research Mayo Clinic Jacksonville · Jacksonville, United States · NIH-11592359

  • Lipid-gene Profiles in Septic ARDS

    A Mayo Clinic team is studying how dysfunctional HDL in sepsis relates to different ARDS patient outcomes, aiming to find features that could guide better treatment.

    NIH research Mayo Clinic Jacksonville · Jacksonville, United States · NIH-11575353

  • APOE4 and brain lymphatic drainage in Alzheimer's disease

    This NIH grant investigates how the APOE4 gene affects the brain’s lymphatic system and its role in Alzheimer’s disease, with potential implications for people at risk.

    NIH research Mayo Clinic Jacksonville · Jacksonville, United States · NIH-11463446

  • Tumor Susceptibility Gene 101: a microglial therapy approach to protect memory in Alzheimer’s disease

    A Mayo Clinic team is studying a protein called TSG101 in brain immune cells to slow or prevent cognitive decline in Alzheimer’s disease.

    NIH research Mayo Clinic Jacksonville · Jacksonville, United States · NIH-11463429

  • ABCA7 loss of function and Alzheimer's disease

    This grant examines how changes in ABCA7, a brain lipid transporter, may influence Alzheimer's disease risk and progression in people.

    NIH research Mayo Clinic Jacksonville · Jacksonville, United States · NIH-11463253

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.